When Emma was still being seen at the NIH twice a week, we were talking with her physician’s assistant about her t-shirt fundraiser and her Facebook group. After hearing what Emma was doing with these activities, they asked her to be their new pediatric patient advocate, helping newer pediatric patients with advice on how to cope with treatments. This seemed to be another way we could help.
Thank you for attending the 2017 Patient and Family Conference in Kansas City, MO.
Although hematopoietic growth factors are at high levels in
Join us for a haunting event to benefit the
No abstract avilable.
Despite being recommended as first-line immunosuppressive therapy in severe
Directed immunotherapy at the programmed cell death-1 receptor has demonstrated efficacy in non-small-cell lung cancer, metastatic melanoma, and various other malignancies. Immune checkpoint inhibitors are innovative therapies producing some impressive clinical responses with a more manageable adverse effect profile when compared to traditional
No abstract available.
Newer treatment modalities are being investigated to improve upon historical outcomes with standard immunosuppressive therapy (IST) in